Major shareholders and senior executives collectively reduce their holdings of Yingke medical, with a 17.2% drop in the opening price

Chinese Restaurant Brands Going Global: What Keeps Customers Coming Back After the Opening?

How long can the queues outside a brand’s first overseas store last? And how many customers drawn in by the novelty will become regulars? For Chinese restaurant brands expanding internationally, opening a store is only the beginning of the challenge of building a local business and retaining customers.

SHEIN Expands Polish Logistics Hub with EUR 500 Million Investment

SHEIN（希音）announced a further EUR 500 million investment to expand its European logistics hub near Wrocław, Poland. The company said the investment would bring its cumulative spending in Poland since 2022 to EUR 1 billion and support faster order fulfilment across Europe.

Sino Biopharm and Boehringer Ingelheim Sign Option and License Deal for Six Cancer Programs

Sino Biopharmaceutical（中国生物制药）and Boehringer Ingelheim（勃林格殷格翰）announced an option and license agreement on November 4 covering six preclinical cancer programs. Sino Biopharm will receive USD 358 million in upfront and near-term payments and may receive up to USD 7 billion in additional option, development, regulatory and commercial milestone payments.

EU Conditionally Clears JD.com’s Takeover of CECONOMY

The European Commission conditionally approved JD.com’s（京东）proposed acquisition of German electronics retailer CECONOMY AG on November 3. The decision clears the transaction under the EU’s Foreign Subsidies Regulation and makes a set of ten-year commitments binding on the companies.

Wantai Launches Nine-Valent HPV Vaccine Cecolin 9 in Thailand

Wantai Biological（万泰生物）said on November 2 that its nine-valent HPV vaccine, Cecolin 9（馨可宁9）, had launched in Thailand. The product was jointly developed by its subsidiary Xiamen Innovax Biotech（厦门万泰沧海生物技术有限公司）and Xiamen University（厦门大学）.